Company news
Johnson & Johnson Nordic AB, a Johnson & Johnson company, announced the acquisition of Amic, a privately held Swedish developer of in vitro diagnostic technologies for use in point-of-care and near-patient settings.
Johnson & Johnson Nordic AB, a Johnson & Johnson company, announced the acquisition of Amic, a privately held Swedish developer of in vitro diagnostic technologies for use in point-of-care and near-patient settings.
Get the most out of
Register for free and enjoy unlimited access to: